101 related articles for article (PubMed ID: 31184616)
1. [BRCA1 and Estrogen Receptor α Expression Regulation in Breast Cancer Cells].
Scherbakov AM; Shestakova EA; Galeeva KE; Bogush TA
Mol Biol (Mosk); 2019; 53(3):502-512. PubMed ID: 31184616
[TBL] [Abstract][Full Text] [Related]
2. Arsenic‑induced BRCA1 CpG promoter methylation is associated with the downregulation of ERα and resistance to tamoxifen in MCF7 breast cancer cells and mouse mammary tumor xenografts.
Selmin OI; Donovan MG; Skovan B; Paine-Murieta GD; Romagnolo DF
Int J Oncol; 2019 Mar; 54(3):869-878. PubMed ID: 30664189
[TBL] [Abstract][Full Text] [Related]
3. Estrogen upregulation of BRCA1 expression with no effect on localization.
Romagnolo D; Annab LA; Thompson TE; Risinger JI; Terry LA; Barrett JC; Afshari CA
Mol Carcinog; 1998 Jun; 22(2):102-9. PubMed ID: 9655254
[TBL] [Abstract][Full Text] [Related]
4. The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
Gorski JJ; Kennedy RD; Hosey AM; Harkin DP
Clin Cancer Res; 2009 Mar; 15(5):1514-8. PubMed ID: 19223511
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
6. Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells.
Mahalingaiah PK; Ponnusamy L; Singh KP
Breast Cancer Res Treat; 2015 Aug; 153(1):41-56. PubMed ID: 26208486
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
[TBL] [Abstract][Full Text] [Related]
8. 17β-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells.
Belkaid A; Duguay SR; Ouellette RJ; Surette ME
BMC Cancer; 2015 May; 15():440. PubMed ID: 26022099
[TBL] [Abstract][Full Text] [Related]
9. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
Sampath D; Winneker RC; Zhang Z
Endocrinology; 2001 Jun; 142(6):2540-8. PubMed ID: 11356703
[TBL] [Abstract][Full Text] [Related]
10. Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis.
Rajan A; Nadhan R; Latha NR; Krishnan N; Warrier AV; Srinivas P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188482. PubMed ID: 33260050
[TBL] [Abstract][Full Text] [Related]
11. SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1.
Cairns J; Ingle JN; Wickerham LD; Weinshilboum R; Liu M; Wang L
PLoS Genet; 2017 Oct; 13(10):e1007031. PubMed ID: 28968398
[TBL] [Abstract][Full Text] [Related]
12. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer.
Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T
J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581
[TBL] [Abstract][Full Text] [Related]
13. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
O'Regan RM; Osipo C; Ariazi E; Lee ES; Meeke K; Morris C; Bertucci A; Sarker MA; Grigg R; Jordan VC
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2255-63. PubMed ID: 16609042
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Activation of
Donovan MG; Selmin OI; Doetschman TC; Romagnolo DF
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31652854
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
16. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
Pons DG; Nadal-Serrano M; Blanquer-Rossello MM; Sastre-Serra J; Oliver J; Roca P
J Cell Biochem; 2014 May; 115(5):949-58. PubMed ID: 24375531
[TBL] [Abstract][Full Text] [Related]
17. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
[TBL] [Abstract][Full Text] [Related]
19. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modulation of BRCA1 and BRCA2 gene expression by equol in breast cancer cell lines.
Bosviel R; Durif J; Déchelotte P; Bignon YJ; Bernard-Gallon D
Br J Nutr; 2012 Oct; 108(7):1187-93. PubMed ID: 22217331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]